Though the article does not detail which perinatal complications have been linked to Lexapro (escitalopram), a piece by C. Bellantuono et al. published in the November, 2012 edition of Human Psychopharmacology drew that link.
Lexapro is a selective serotonin reuptake inhibitor (SSRI). This drug and drugs like it work to regulate levels of serotonin in the brain, a neurotransmitter that plays an important role in mood, sleep, appetite, and fetal development. SSRI drugs work to increase the amount of serotonin in patient synapses, and it has been demonstrated by a number of studies that the drug passes through the placenta to a developing child. The biochemical mechanism by which SSRIs hamper neonatal development is as yet unknown, but many correlational studies have illustrated important connections.
This study performed a literature review, and found that “exposure to ESC seems to be significantly associated with some PCs.” For clarity, ESC is shorthand for escitalopram, and PCs means “perinatal complications.”
Due to the fact that the manufacturers of many SSRIs linked to birth defects and perinatal complications have failed to adequately update warning labels to reflect much of this contemporary research, a number of SSRI Birth Defects Lawsuits have been filed.
If you or a loved one used SSRIs and gave birth to a child with a congenital malformation or who had perinatal complications, you may be entitled to significant financial compensation. For a free, no-obligation case consultation, contact our team of SSRI birth defect lawyers at the information provided below. We have the experience, resources, and skills required to win the justice you deserve. Call today and see how we can help.
(855) 452 – 5529